
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer
Yan Zhao, Yangyang Yu, Xiangmin Li, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Yan Zhao, Yangyang Yu, Xiangmin Li, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion
Xixi Liu, Kenneth K.W. To, Qinsong Zeng, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Xixi Liu, Kenneth K.W. To, Qinsong Zeng, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Comprehensive analysis of lipid metabolic signatures identified CEBPD promotes breast cancer cell proliferation
Yu Zhao, Huan He, Linyan Huang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yu Zhao, Huan He, Linyan Huang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Tumor-derived extracellular vesicles: key drivers of immunomodulation in breast cancer
Jieming Li, Shuo Yu, Min Rao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jieming Li, Shuo Yu, Min Rao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Role of Triple‐Negative Breast Cancer‐Derived Extracellular Vesicles in Metastasis: Implications for Therapeutics and Biomarker Development
X. Wan, Liqi Yang, Linjun Wu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
X. Wan, Liqi Yang, Linjun Wu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Basic biology and roles of CEBPD in cardiovascular disease
T Li, Shaoling Lin, Ying Zhu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
T Li, Shaoling Lin, Ying Zhu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Mechanisms of reduced efficacy of HER2-targeted therapy in HER2-low breast cancer by long-term nicotine exposure in patient-derived xenograft mouse tumor models
Yu-Hsuan Lin, Yuan‐Soon Ho, Bu‐Miin Huang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 294, pp. 118071-118071
Closed Access
Yu-Hsuan Lin, Yuan‐Soon Ho, Bu‐Miin Huang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 294, pp. 118071-118071
Closed Access
Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs
Abeer A. I. Hassanin, Kenneth S. Ramos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10674-10674
Open Access
Abeer A. I. Hassanin, Kenneth S. Ramos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10674-10674
Open Access